Ara
Toplam kayıt 550, listelenen: 461-470
Global, Regional, And National Burden Of Neurological Disorders, 1990-2016: A Systematic Analysis For The Global Burden Of Disease Study 2016
(2019)
Background Neurological disorders are increasingly recognised as major causes of death and disability worldwide. The aim of this analysis from the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2016 is ...
Exon 2: Is It The Good Police In Familial Mediterranean Fever?
(2019)
Objective: Familial Mediterranean fever (FMF) is the most common autoinflammatory disease. Most of the identified disease-causing mutations are located on exon 10. As the number of studies about the effect of the exonal ...
Escmid White Paper: A Guide On Escmid Guidance Documents
(2019)
Background and aim: The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) aims to further develop its role in international medical and scientific guidance in the field of Clinical Microbiology and ...
Standards Of Care For Hypoparathyroidism In Adults: A Canadian And International Consensus
(2019)
Purpose: To provide practice recommendations for the diagnosis and management of hypoparathyroidism in adults. Methods: Key questions pertaining to the diagnosis and management of hypoparathyroidism were addressed following ...
Evaluation Of Cancer Risk In Patients With Periodontal Diseases
(2019)
Background/aim In this study, we aimed to assess the cancer risk among patients with periodontal disease. Materials and methods Patients diagnosed with periodontal diseases at Hacettepe University between 2007 and 2012 ...
Effects Of Smoking On Hematological Parameters And Ferritin Levels
(2019)
Aim: Cigarette smoking is associated with an increased risk of cardiovascular diseases, including coronary artery disease, peripheral vascular disease, ischemic heart disease, atherosclerosis, myocardial infarction, and ...
Effects Of Telmisartan And Losartan Treatments On Bone Turnover Markers In Patients With Newly Diagnosed Stage I Hypertension
(2019)
Introduction: Telmisartan is an angiotensin-II receptor type-1 blocker and a partial agonist for peroxisome proliferator-activated receptor-γ. The aim of this study was to determine the potential effects of telmisartan on ...
Effects Of Hormone Replacement Therapy On Sarcopenia: Is It Real?
(2019)
See the Reply by .